Synlait: FDA approval for Munchkin infant formula is imminent
The US is a less cluttered market for imported infant formula.
Synlait Milk says the US Food & Drug Administration's delayed approval of Munchkin’s stage one infant formula product to be sold in America is imminent.
The Munchkin “grass fed” infant formula, which is being manufactured by Synlait, was expected to have been launched in May.
The FDA approved
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Jenny Ruth
Thu, 20 Jul 2017
Thu, 20 Jul 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Synlait: FDA approval for Munchkin infant formula is imminent
68591